Manmeet Soni - 19 May 2022 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
19 May 2022
Net transactions value
$0
Form type
4
Filing time
23 May 2022, 20:53:14 UTC
Previous filing
05 Jan 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 19 May 2022 Common Stock 20,000 $2.14 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +116,005 $0.000000 116,005 19 May 2022 Common Stock 116,005 $2.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022.
F2 The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022.